DyDo Group Holdings Inc
TSE:2590
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DyDo Group Holdings Inc's latest stock split occurred on Jan 18, 2024
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, DyDo Group Holdings Inc traded at 5910 per share. Afterward, the share price was about 2923.5325.
The adjusted shares began trading on Jan 18, 2024. This was the only stock split in DyDo Group Holdings Inc's history.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 24, 2026
|
|
Cue Biopharma Inc
NASDAQ:CUE
|
1-for-30
/30
|
0.5542 16.626 USD | 17.695 17.695 USD |
|
Apr 24, 2026
|
|
Medical Data Vision Co Ltd
TSE:3902
|
2-for-7253607
/3626803.5
|
1684 1684 JPY | N/A |
|
Apr 24, 2026
|
E
|
ESGL Holdings Ltd
NASDAQ:ESGL
|
1-for-3
/3
|
2.35 7.05 USD | 2.93 2.93 USD |
|
Apr 24, 2026
|
|
Metro Mining Ltd
ASX:MMI
|
1-for-20
/20
|
0.067 1.34 AUD | 1.3 1.3 AUD |
|
Apr 24, 2026
|
L
|
La Comer SAB de CV
OTC:LCMRF
|
115-for-114
x1.0087719298246
|
2.4715 2.4341 USD | 2.45 2.45 USD |
CUE
3902
MMI
DyDo Group Holdings Inc
Glance View
DyDo Group Holdings, Inc. engages in the production and sale of beverages. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,029 full-time employees. The company went IPO on 2001-08-09. The firm operates through three business segments. The Beverage Sales segment is involved in the planning, development and sale of various soft drinks to consumers through convenience stores and vending machines. Through a consolidated subsidiary, this segment is also engaged in the manufacture and sale of drinkable preparations such as quasi drugs. The Contract Drink Manufacturing segment is engaged in the contract manufacture of drinkable preparations, including drugs and medicines, quasi drugs, as well as soft drinks. The Foods Manufacture and Sale segment is involved in the manufacture and sale of fruit jellies.
